Cas:537-91-7 Megasul manufacturer & supplier

We serve Chemical Name:Megasul CAS:537-91-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Megasul

Chemical Name:Megasul
CAS.NO:537-91-7
Synonyms:Bis(m-nitrophenyl) disulfide;Bis(3-nitrophenyl) Disulfide;3-Nitrophenyl disulfide;Megasul;NITROPHENIDE;1,1′-Disulfanediylbis(3-nitrobenzene);Disulfide, bis(3-nitrophenyl);Disulfide, bis(m-nitrophenyl) (8CI);m,m’-Dinitrodiphenyl disulfide;Bis(3-nitrophenyl)disulfide;Disulfide, bis(m-nitrophenyl);1-nitro-3-[(3-nitrophenyl)disulfanyl]benzene;MFCD00003573;3,3′-Dinitrodiphenyl disulfide;EINECS 208-677-6
Molecular Formula:C12H8N2O4S2
Molecular Weight:308.333
HS Code:2930909090

Physical and Chemical Properties:
Melting point:78-80 °C(lit.)
Boiling point:443.6±30.0 °C at 760 mmHg
Density:1.5±0.1 g/cm3
Index of Refraction:1.718
PSA:142.24000
Exact Mass:307.992554
LogP:4.06

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 3077 9/PG 3
Packing Group:III


Contact us for information like Bis(m-nitrophenyl) disulfide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,EINECS 208-677-6 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,1′-Disulfanediylbis(3-nitrobenzene) Use and application,Disulfide, bis(m-nitrophenyl) technical grade,usp/ep/jp grade.


Related News: The inhaled two-dose candidate is modified from CanSinoBIO’s injected COVID-19 jab Ad5-nCoV vaccine, which is already approved in China and other countries around the world. 1-[2-(5-chloro-1-methyl-1H-imidazol-2-ylmethylsulfanyl)-ethyl]-3-methyl-thiourea manufacturers We are committed to bringing safe, effective vaccines to Ireland and other markets as quickly as possible, and Charles River will continue to be an important partner in this regard.” N-(2-(4-((1-(4-fluorobenzyl)-1H-benzo[d]imidazol-2-yl)amino)piperidin-1-yl)ethyl)-4-(pyridin-2-yl)thiazol-2-amine suppliers Biogen’s Alzheimer’s drug, Aduhelm, generated $2 million in revenue in the first few weeks of its approval, the company said Thursday in releasing its second-quarter earnings along with an open letter about the controversial drug. 2-[(4-tert-butyl-benzenesulfonyl)-p-tolyl-amino]-N-ethyl-N-(1H-indol-3-ylmethyl)-acetamide vendor & factory.